Dr. Kamil M. Yenice is an Associate Professor at the University of Chicago in the Department of Radiation & Cellular Oncology. He received his Ph.D. in Experimental Physics from the University of Toledo in 1993. After a two-year appointment as a lecturer at Penn-State University-Erie he studied Medical Physics at Wayne State University. He started his Medical Physics career in New York Hospital, Cornell Medical Center, in New York City, followed by a faculty position at Memorial Sloan Kettering Cancer Center before joining as faculty in Radiation Oncology at the University of Chicago in 2005.
He is currently Chief of Clinical Physics and Director of the Medical Physics Residency Program. His research focuses on the use of image guided stereotactic treatment delivery methods and improving quality assurance aspects of patient treatments. He has published on the implementation of stereotactic delivery methods in SRS and SBRT and also as the co-chair for the AAPM TG-101 Report on SBRT.
Currently, he serves as Physics co-chair of the ASTRO APEx committee and chair of AAPM WGIMRT. He is actively engaged in professional activities of both ASTRO and AAPM and advocates for patient safety and practice accreditation for improved quality of care. He is board certified by the ABMP.
A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT.
A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT. Blood Adv. 2023 02 14; 7(3):285-292.
PMID: 35851593
Knowledge-based planning for multi-isocenter VMAT total marrow irradiation.
Knowledge-based planning for multi-isocenter VMAT total marrow irradiation. Front Oncol. 2022; 12:942685.
PMID: 36267964
A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT.
Tran MC, Hasan Y, Wang AY, Yenice KM, Partouche J, Stock W, Larson RA, Kosuri S, LaBelle JL, Kline J, Riedell PA, Artz AS, Weichselbaum RR, Bishop MR, Aydogan B, Liu H. A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT. Blood Adv. 2022 Jul 18.
PMID: 35851593
Linear accelerator-based stereotactic radiosurgery for glossopharyngeal neuralgia is safe and effective - Report of two cases.
Linear accelerator-based stereotactic radiosurgery for glossopharyngeal neuralgia is safe and effective - Report of two cases. J Radiosurg SBRT. 2022; 8(2):151-153.
PMID: 36275126
Dosimetric feasibility of brain stereotactic radiosurgery with a 0.35 T MRI-guided linac and comparison vs a C-arm-mounted linac.
Dosimetric feasibility of brain stereotactic radiosurgery with a 0.35 T MRI-guided linac and comparison vs a C-arm-mounted linac. Med Phys. 2020 Nov; 47(11):5455-5466.
PMID: 32996591
Physician review of image registration and normal structure delineation.
Physician review of image registration and normal structure delineation. J Appl Clin Med Phys. 2020 Nov; 21(11):80-87.
PMID: 32986307
ACR-ASTRO Practice Parameter for the Performance of Stereotactic Body Radiation Therapy.
ACR-ASTRO Practice Parameter for the Performance of Stereotactic Body Radiation Therapy. Am J Clin Oncol. 2020 08; 43(8):545-552.
PMID: 32404596
Estimation of secondary cancer risk after radiotherapy in high-risk prostate cancer patients with pelvic irradiation.
Estimation of secondary cancer risk after radiotherapy in high-risk prostate cancer patients with pelvic irradiation. J Appl Clin Med Phys. 2020 Sep; 21(9):82-89.
PMID: 32671989
Frame-based radiosurgery of multiple metastases using single-isocenter volumetric modulated arc therapy technique.
Frame-based radiosurgery of multiple metastases using single-isocenter volumetric modulated arc therapy technique. J Appl Clin Med Phys. 2019 Aug; 20(8):21-28.
PMID: 31328368
Validation of MLC-based linac radiosurgery for trigeminal neuralgia.
Validation of MLC-based linac radiosurgery for trigeminal neuralgia. J Appl Clin Med Phys. 2018 Jul; 19(4):214-221.
PMID: 29901278